|
HUS1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.64601665630926E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.11528580709819E-13 |
| Normal-vs-Stage2 |
1.29979999996532E-06 |
| Normal-vs-Stage3 |
5.86197757002083E-14 |
| Normal-vs-Stage4 |
5.03479999913736E-08 |
| Stage1-vs-Stage2 |
4.451400E-01 |
| Stage1-vs-Stage3 |
6.338400E-02 |
| Stage1-vs-Stage4 |
4.850800E-01 |
| Stage2-vs-Stage3 |
6.141700E-02 |
| Stage2-vs-Stage4 |
2.875400E-01 |
| Stage3-vs-Stage4 |
6.449600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.94129173741931E-13 |
| Normal-vs-AfricanAmerican |
4.83919999960669E-07 |
| Normal-vs-Asian |
2.17820000036895E-07 |
| Caucasian-vs-AfricanAmerican |
9.422000E-01 |
| Caucasian-vs-Asian |
4.618800E-01 |
| AfricanAmerican-vs-Asian |
6.518800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.2358781492926E-12 |
| Normal-vs-Female |
1.84774417988365E-12 |
| Male-vs-Female |
6.766000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.20700116568173E-11 |
| Normal-vs-Age(41-60Yrs) |
1.8384183064768E-12 |
| Normal-vs-Age(61-80Yrs) |
1.96940019847602E-10 |
| Normal-vs-Age(81-100Yrs) |
4.05880000000636E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.351000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.862600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.944800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.642200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.804600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.053200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.309830E-02 |
| Classical-VS-Follicular |
5.100200E-01 |
| Classical-VS-Other |
5.585600E-01 |
| Classical-VS-Normal |
5.2146065243619E-12 |
| Tall-VS-Follicular |
1.090820E-01 |
| Tall-VS-Other |
6.401800E-01 |
| Tall-VS-Normal |
7.50930428949914E-11 |
| Follicular-VS-Other |
7.510600E-01 |
| Follicular-VS-Normal |
2.70239997046673E-09 |
| Other-VS-Normal |
1.056980E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.79629702410512E-13 |
| Normal-vs-N1 |
1.28019994605211E-09 |
| N0-vs-N1 |
5.820200E-01 |
|
|
